This is a community-generated profile. If you would like to claim it, please .
Galectin Therapeutics Funding
$6.4M
88 rounds
Galectin Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 8 rounds, totaling in an amount of $6.4M. Their most recent funding was raised on January 6, 2011.
Funding Rounds
U
$3000000B
$570000B
$310000B
$335000U
$489000UnknownFeb 2010
B
$325000B
$500000B
$900000Investors of Galectin Therapeutics
National Institutes of Health
Rounds
U